Pfizer (PFE) Stock Forecast & Price Target
PFE Analyst Ratings
Moderate Buy
8Buy14Hold1Sell
Based on 23 analysts giving stock ratings to Pfizer in the past 3 months
PFE Stock 12 Month Forecast
Average Price Target
MXN 559.26▼(-2.23% Downside)Based on 23 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is MXN 559.26 with a high forecast of MXN 679.76 and a low forecast of MXN 472.05. The average price target represents a -2.23% change from the last price of MXN 572.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 679.76
AverageMXN 559.26
LowMXN 472.05
Highest Price TargetHighestMXN 679.76Average Price TargetMXN 559.26Lowest Price TargetLowestMXN 472.05
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | MXN 509.82 | hold | -10.87%Downside | Reiterated | 10/27/26 | ||
| Trung Huynh | RBC Capital | MXN 472.05 | hold | -17.47%Downside | Reiterated | 10/27/26 | ||
| Vamil Divan | Guggenheim | MXN 585.35 | buy | 2.33%Upside | Reiterated | 10/27/26 | ||
| Akash Tewari | Jefferies | MXN 679.76 | buy | 18.84%Upside | Reiterated | 10/26/26 | ||
| Louise Chen | Scotiabank | MXN 623.11 | buy | 8.94%Upside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | MXN 547.58 | hold | -4.27%Downside | Reiterated | 10/25/26 | ||
| Luisa Hector | Berenberg Bank | MXN 472.05 | hold | -17.47%Downside | Reiterated | 10/20/26 | ||
| Derek Archila | Wells Fargo | MXN 528.70 | hold | -7.57%Downside | Reiterated | 10/16/26 | ||
| Evan Seigerman | BMO Capital | MXN 660.88 | buy | 15.54%Upside | Reiterated | 10/12/26 | ||
| Jason Gerberry | Bank of America Securities | MXN 509.82→MXN 547.58 | hold | -4.27%Downside | Reiterated | 10/09/26 | ||
| Chris Schott | J.P. Morgan | MXN 528.70→MXN 566.47 | hold | -0.97%Downside | Assigned | 10/09/26 | ||
| Michael Yee | UBS | MXN 509.82 | hold | -10.87%Downside | Reiterated | 10/09/26 | ||
| Carter Gould | Cantor Fitzgerald | MXN 509.82→MXN 528.70 | hold | -7.57%Downside | Assigned | 10/08/26 | ||
| Nico Chen | DBS | MXN 660.88 | buy | 15.54%Upside | Reiterated | 10/08/26 | ||
| Terence Flynn | Morgan Stanley | MXN 528.70 | hold | -7.57%Downside | Assigned | 10/07/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | 10/27/26 | MXN 509.82 | hold | -10.87%Downside | Reiterated | Citi | ||
| Trung Huynh | 10/27/26 | MXN 472.05 | hold | -17.47%Downside | Reiterated | RBC Capital | ||
| Vamil Divan | 10/27/26 | MXN 585.35 | buy | 2.33%Upside | Reiterated | Guggenheim | ||
| Akash Tewari | 10/26/26 | MXN 679.76 | buy | 18.84%Upside | Reiterated | Jefferies | ||
| Louise Chen | 10/26/26 | MXN 623.11 | buy | 8.94%Upside | Reiterated | Scotiabank | ||
| Courtney Breen | 10/25/26 | MXN 547.58 | hold | -4.27%Downside | Reiterated | Bernstein | ||
| Luisa Hector | 10/20/26 | MXN 472.05 | hold | -17.47%Downside | Reiterated | Berenberg Bank | ||
| Derek Archila | 10/16/26 | MXN 528.70 | hold | -7.57%Downside | Reiterated | Wells Fargo | ||
| Evan Seigerman | 10/12/26 | MXN 660.88 | buy | 15.54%Upside | Reiterated | BMO Capital | ||
| Jason Gerberry | 10/09/26 | MXN 509.82→MXN 547.58 | hold | -4.27%Downside | Reiterated | Bank of America Securities | ||
| Chris Schott | 10/09/26 | MXN 528.70→MXN 566.47 | hold | -0.97%Downside | Assigned | J.P. Morgan | ||
| Michael Yee | 10/09/26 | MXN 509.82 | hold | -10.87%Downside | Reiterated | UBS | ||
| Carter Gould | 10/08/26 | MXN 509.82→MXN 528.70 | hold | -7.57%Downside | Assigned | Cantor Fitzgerald | ||
| Nico Chen | 10/08/26 | MXN 660.88 | buy | 15.54%Upside | Reiterated | DBS | ||
| Terence Flynn | 10/07/26 | MXN 528.70 | hold | -7.57%Downside | Assigned | Morgan Stanley |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Pfizer
3 Months
Success Rate25/34 ratings generated profit
74%
Average Return
+4.07%
Copying Vamil Divan's trades and holding each position for 3 Months would result in 73.53% of your transactions generating a profit, with an average return of +4.07% per trade.
1 Year
Success Rate30/34 ratings generated profit
88%
Average Return
+11.54%
Copying Vamil Divan's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +11.54% per trade.
2 Years
Success Rate31/34 ratings generated profit
91%
Average Return
+17.07%
Copying Vamil Divan's trades and holding each position for 2 Years would result in 91.18% of your transactions generating a profit, with an average return of +17.07% per trade.
PFE Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 21 | 20 | 20 | 14 | 19 |
| Hold | 45 | 40 | 37 | 25 | 35 |
| Sell | 8 | 5 | 3 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 74 | 65 | 60 | 40 | 55 |
In the current month, PFE has received 19 Buy Ratings, 35 Hold Ratings, and 1 Sell Ratings. PFE average Analyst price target in the past 3 months is 559.26.
PFE Financial Forecast
HighMXN 15.59
ConsensusMXN 13.70
LowMXN 10.52
PFE Earnings Forecast
Next quarter’s earnings estimate for PFE is MXN 13.70 with a range of MXN 10.52 to MXN 15.59. The previous quarter’s EPS was MXN 14.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 304B
ConsensusMXN 298B
LowMXN 276B
PFE Sales Forecast
Next quarter’s sales forecast for PFE is MXN 297.79B with a range of MXN 276.01B to MXN 303.58B. The previous quarter’s sales results were MXN 282.43B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
PFE Stock Forecast FAQ
What is MX:PFE’s average 12-month price target, according to analysts?
Based on analyst ratings, Pfizer’s 12-month average price target is Mex$559.26.
What is MX:PFE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MX:PFE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pfizer a Buy, Sell or Hold?
Pfizer has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 14 hold ratings and 1 sell ratings.
What is Pfizer’s share price target?
The average share price target for Pfizer is Mex$559.26. This is based on 23 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$679.76, and the lowest forecast is Mex$472.05. The average share price target represents a 2.23% decrease from the current price of Mex$572.
What do analysts say about Pfizer?
Pfizer’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Street analysts.
How can I buy shares of Pfizer?
To buy shares of MX:PFE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.